Nifedipine-sensitive blood pressure component in hypertensive models characterized by high activity of either sympathetic nervous system or renin-angiotensin system

Physiological Research

Volumn 63, Issue 1, 2014, Pages 13-26

  Zicha, J ^a   Dobesova Z ^a   Behuliak, M ^a   Pinterova M ^a   Kunes J ^a   Vaneckova I ^a  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

Genetic hypertension; Nitric oxide; Renin angiotensin system; Sympathetic nervous system

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; NIFEDIPINE;

ADRENERGIC SYSTEM; ANIMAL; BLOOD PRESSURE; DISEASE MODEL; DRUG EFFECTS; HYPERTENSION; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZATION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPONTANEOUSLY HYPERTENSIVE RAT; TRANSGENIC RAT; WISTAR KYOTO RAT;

ANIMALS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DISEASE MODELS, ANIMAL; HYPERTENSION; MALE; NIFEDIPINE; RANDOM ALLOCATION; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RATS, TRANSGENIC; RENIN-ANGIOTENSIN SYSTEM; SYMPATHETIC NERVOUS SYSTEM;

EID: 84897003538     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. BADER M, ZHAO Y, SANDER M, LEE MA, BACHMANN J, BÖHM M, DJAVIDANI B, PETERS J, MULLINS JJ, GANTEN D: (1992) Role of tissue renin in the pathophysiology of hypertension in TGR(mREN2)27 rats. Hypertension 19: 681-686.
2. 2+ channel surface expression and cerebrovascular constriction in genetic hypertension. Hypertension 60: 1006-1015, 2012.
3. BERECEK KH, KIRK KA, NAGAHAMA S, OPARIL S: Sympathetic function in spontaneously hypertensive rats after chronic administration of captopril. Am J Physiol 252: H796-H806, 1987.
4. BISHOP JE, KIERNAN LA, MONTGOMERY HE, GOHLKE P, MCEWAN JR: (2000) Raised blood pressure, not renin-angiotensin systems, causes cardiac fibrosis in TGR m(Ren2)27 rats. Cardiovasc. Res. 47, 57-67.
5. BÖHM M, ZOLK O, FLESCH M, SCHIFFER F, SCHNABEL P, STASCH JP, KNORR A: (1998) Effects of angiotensin II type 1 receptor blockade and angiotensin-converting enzyme inhibition on cardiac betaadrenergic signal transduction. Hypertension 31: 747-754.
6. BRAYDEN JE, NELSON MT: Regulation of arterial tone by activation of calcium-dependent potassium channels. Science 256: 532-535, 1992.
7. COX RH, RUSCH NJ: New expression profiles of voltage-gated ion channels in arteries exposed to high blood pressure. Microcirculation 9: 243-257, 2002.
8. DE CHAMPLAIN J: Pre-and postsynaptic adrenergic dysfunctions in hypertension. J Hypertens 8 (Suppl 7): S77-S85, 1990.
9. DOBEŠOVÁ Z, KUNEŠ J, ZICHA J: The altered balance between sympathetic nervous system and nitric oxide in salt hypertensive Dahl rats: ontogenetic and F2 hybrid studies. J Hypertens 20: 945-955, 2002.
10. EARLEY S, WALDRON BJ, BRAYDEN JE: Critical role for transient receptor potential channel TRPM4 in myogenic constriction of cerebral arteries. Circ Res 95: 922-929, 2004.
11. GODFRAIND T, KAZDA S, WIBO M: Effects of a chronic treatment by nisoldipine, a calcium antagonistic dihydropyridine, on arteries of spontaneously hypertensive rats. Circ Res 68: 674-682, 1991.
12. 2+ release from the sarcoplasmic reticulum is required for sustained TRPM4 activity in cerebral artery smooth muscle cells. Am J Physiol Cell Physiol 299: C279-C288, 2010.
13. HEAD RJ: Hypernoradrenergic innervation: its relationship to functional and hyperplastic changes in the vasculature of the spontaneously hypertensive rat. Blood Vessels 26: 1-20, 1989.
14. HERMSMEYER K: Differences of calcium channels in vascular muscle in hypertension. Am J Hypertens 4: 412S-415S, 1991.
15. HIRTH-DIETRICH C, STASCH JP, GANTEN D, LUFT FC: (1994) Renal effects of captopril and nitrendipine in transgenic rats with an extra renin gene. Hypertension 23: 626-631.
16. HOJNÁ S, KADLECOVÁ M, DOBEŠOVÁ Z, VALOUŠKOVÁ V, ZICHA J, KUNEŠ J: (2007) The participation of brain NO synthase in blood pressure control of adult spontaneously hypertensive rats. Mol. Cell. Biochem. 297: 21-29.
17. 2+-permeable cation channel. Circ Res 88: 325-332, 2001.
18. 2+ channels by cAMP and cGMP in vascular smooth muscle cells. Circ Res 73: 1128-1137, 1993.
19. KAZDA S, GARTHOFF B, KNORR A: Interference of calcium antagonist nisoldipine with the abnormal response of vessels from hypertensive rats to alpha-adrenergic stimulation. J Cardiovasc Pharmacol 7 (Suppl 6): S61-S65, 1985.
20. KHARADE SV, SONKUSARE SK, SRIVASTAVA AK, THAKALI KM, FLETCHER TW, RHEE SW, RUSCH NJ: The β3 subunit contributes to vascular calcium channel upregulation and hypertension in angiotensin II-infused C57BL/6 mice. Hypertension 61: 137-142, 2013.
21. KNOT HJ, NELSON MT: Regulation of membrane potential and diameter by voltage-dependent K+ channels in rabbit myogenic cerebral arteries. Am J Physiol 269: H348-H355, 1995.
22. KUNEŠ J, DOBEŠOVÁ Z, ZICHA J: Altered balance of main vasopressor and vasodepressor systems in rats with genetic hypertension and hypertriglyceridaemia. Clin Sci 102: 269-277, 2002.
23. KUNEŠ J, HOJNÁ S, KADLECOVÁ M, DOBEŠOVÁ Z, RAUCHOVÁ H, VOKURKOVÁ M, LOUKOTOVÁ J, PECHÁŇOVÁ O, ZICHA J: (2004) Altered balance of vasoactive systems in experimental hypertension: the role of relative NO deficiency. Physiol. Res. 53 (Suppl. 1): S23-S34.
24. LEWIS SJ, BHOPATKAR MY, WALTON TM, BATES JN: Role of voltage-sensitive calcium-channels in nitric oxide-mediated vasodilation in spontaneously hypertensive rats. Eur J Pharmacol 528: 144-149, 2005.
25. LÍŠKOVÁ S, KUNEŠ J, ZICHA J: Nifedipine-sensitive vascular reactivity of femoral arteries in WKY: the effects of pertussis toxin pretreatment and endothelium removal. Physiol Res 56: 663-666, 2007.
26. LIU H, XIONG Z, SPERELAKIS N: Cyclic nucleotides regulate the activity of L-type calcium channels in smooth muscle cells from rat portal vein. J Mol Cell Cardiol 29: 1411-1421, 1997.
27. 2+ currents in small mesenteric artery myocytes from Wistar-Kyoto and spontaneously hypertensive rats. Hypertension 29: 1329-1336, 1997.
28. NARITA H, NAGAO T, YABANA H, YAMAGUCHI I: (1983) Hypotensive and diuretic actions of diltiazem in spontaneously hypertensive and Wistar Kyoto rats. J. Pharmacol. Exp. Ther. 227: 472-477.
29. NELSON MT, STANDEN MB, BRAYDEN JE, WORLEY JF: Noradrenaline contracts arteries by activating voltagedependent calcium channels. Nature 336: 382-385, 1988.
30. OHYA Y, TSUCHIHASHI T, KAGIYAMA S, ABE I, FUJISHIMA M: Single L-type calcium channels in smooth muscle cells from resistance arteries of spontaneously hypertensive rats. Hypertension 31: 1125-1129, 1998.
31. 2+ influx in vascular smooth muscle cells. Hypertension 27: 774-780, 1996.
32. PARK JK, FIEBELER A, MULLER DN, MERVAALA EM, DECHEND R, ABOU-REBYEH F, LUFT FC, HALLER H: (2002) Lacidipine inhibits adhesion molecule and oxidase expression independent of blood pressure reduction in angiotensin-induced vascular injury. Hypertension 39: 685-689.
33. PAULIS L, LÍŠKOVÁ S, PINTÉROVÁ M, DOBEŠOVÁ Z, KUNEŠ J, ZICHA J: Nifedipine-sensitive noradrenergic vasoconstriction is enhanced in spontaneously hypertensive rats: the influence of chronic captopril treatment. Acta Physiol (Oxford) 191: 255-266, 2007.
34. PECHÁŇOVÁ O, DOBEŠOVÁ Z, ČEJKA J, KUNEŠ J, ZICHA J: Vasoactive systems in L-NAME hypertension: the role of inducible NO synthase. J Hypertens 22: 167-173, 2004.
35. 2+ channels: is membrane depolarization the signal? Circ Res 94: e97-e104, 2004.
36. PINTÉROVÁ M, LÍŠKOVÁ S, DOBEŠOVÁ Z, BEHULIAK M, KUNEŠ J, ZICHA J: Impaired control of L-type voltage-dependent calcium channels in experimental hypertension. Physiol Res 58 (Suppl 2): S43-S54, 2009.
37. PINTÉROVÁ M, KAREN P, KUNEŠ J, ZICHA J: Role of nifedipine-sensitive sympathetic vasoconstriction in maintenance of high blood pressure in spontaneously hypertensive rats: effect of Gi-protein inactivation by pertussis toxin. J Hypertens 28: 969-978, 2010.
38. PINTÉROVÁ M, KUNEŠ J, ZICHA J: Altered neural and vascular mechanisms in hypertension. Physiol Res 60: 381-402, 2011.
39. 2+ exchanger mediated Ca entry in purinergically stimulated aorta smooth muscle cells. Circ Res 101: 1030-1038, 2007.
40. 2+ channels in mesenteric and skeletal arteries of SHR. Hypertension 40: 214-219, 2002.
41. SHARMA JN, FERNANDEZ PG, LAHER I, TRIGGLE CR: (1984) Differential sensitivity of Dahl salt-sensitive and Dahl salt-resistant rats to the hypotensive action of acute nifedipine administration. Can. J. Physiol. Pharmacol. 62: 241-243.
42. SONKUSARE S, PALADE PT, MARSH JD, TELEMAQUE S, PESIC A, RUSCH NJ: Vascular calcium channels and high blood pressure. pathophysiology and therapeutic implications. Vascul Pharmacol 44: 131-142, 2006.
43. TAKATA Y, HUTCHINSON JS: (1983) Exaggerated hypotensive responses to calcium antagonists in spontaneously hypertensive rats. Clin. Exp. Hypertens. A 5: 827-847.
44. VANĚČKOVÁ I, DOBEŠOVÁ Z, KUNEŠ J, ZICHA J: (2012) The effects of repeated delivery of angiotensin II AT1 receptor antisense on distinct vasoactive systems in Ren-2 transgenic rats: young vs. adult animals. Hypertens. Res. 35: 761-758.
45. WANG WZ, PANG L, PALADE P: Angiotensin II causes endothelial-dependent increase in expression of CaV1.2 protein in cultured arteries. Eur J Pharmacol 599: 117-120, 2008.
46. WITTE K, HUSER L, KNOTTER B, HECKMANN M, SCHIFFER S, LEMMER B: (2001) Normalisation of blood pressure in hypertensive TGR(mREN2)27 rats by amlodipine vs. enalapril: effects on cardiac hypertrophy and signal transduction pathways. Naunyn-Schmiedebergs Arch. Pharmacol. 363: 101-109.
47. ZHANG JS, VAN MEEL JC, PFAFFENDORF M, ZHANG J, VAN ZWIETEN PA: Calcium dependency of the AT1-receptor mediated effects in the rat portal vein: influence of calcium antagonists. Naunyn-Schmiedebergs Arch Pharmacol 349: 437-442, 1994.
48. ZICHA J, DOBEŠOVÁ Z, KUNEŠ J: Relative deficiency of nitric oxide-dependent vasodilation in salt hypertensive Dahl rats: the possible role of superoxide anions. J Hypertens 19: 247-254, 2001.
49. ZICHA J, DOBEŠOVÁ Z, KUNEŠ J: Antihypertensive mechanisms of chronic captopril or N-acetylcysteine treatment in L-NAME hypertensive rats. Hypertens Res 29: 1021-1027, 2006.
50. ZICHA J, DOBEŠOVÁ Z, PINTÉROVÁ M, BEHULIAK M, KUNEŠ J: Quite different role of renin-angiotensin system (RAS) and sympathetic nervous system (SNS) in blood pressure (BP) regulation in chronically NOdeficient SHR or Wistar rats. J Hypertens 27 (Suppl 2): S299, 2009.
51. ZICHA J, DOBEŠOVÁ Z, BEHULIAK M, KUNEŠ J, VANĚČKOVÁ I: Preventive dietary potassium supplementation in young salt-sensitive Dahl rats attenuates development of salt hypertension by decreasing sympathetic vasoconstriction. Acta Physiol (Oxf) 202: 29-38, 2011.